Evaluation of a chemiluminescent immunoassay for serum HE4
Not Applicable
- Conditions
- Ovarian cancer
- Registration Number
- JPRN-UMIN000006747
- Lead Sponsor
- Abbott Japan Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 470
Inclusion Criteria
Not provided
Exclusion Criteria
1. Ovarian tumor - The dirst treatment is chemotherapy and/or radiotherapy, not laparotomy/surgery. - Pathology results on the primary tumor not available. 2. Healthy subjects - History of bilateral oophorectomy. - Abnormality found in ovary by MRI or PET. - Aware of gynecological diseases. - Aware of internal diseases. - Aware of pregnancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity, Specificity
- Secondary Outcome Measures
Name Time Method